Clinical Trials 101
Clinical trials are research studies involving people. Because people are involved, all clinical trials must be reviewed by Health Canada and shown to be safe. Clinical trials must also be approved by the Ethics Committees of all participating hospitals. These review processes are in place to protect the safety of participants. Only those studies that pass these rigourous approval processes are allowed to recruit patients. To answer this question, we must firstly define the four phases of clinical trials:
A Phase IV trial is sometimes referred to as "post marketing research". It is research on a drug that has already been approved and is being used widely.
|Phase||Number of Participants||Goals|
|Under 100 patients||
|III||Generally, from 100 to thousands of people||
|IV||Generally, from 100 to thousands of people||
Multiple Myeloma Research Network Cinical Trials
The Myeloma Canada Research Network is currently focused on Phase I and Phase II clinical trials with an emphasis on developing trials based on research ideas proposed by members of the network across Canada. For more informtion on active MCRN clinical trials, click here.
To find other clinical trials, please visit the following sites:
This is a Canadian website that allows you to search by cancer type (myeloma) and location. It also includes a sign-up option for those interested in receiving alerts about new myeloma trials.
This website is a service provided by the U.S. National Institute of Health. To find myeloma clinical trials in Canada, click on “Search for Clinical Trials” and type in myeloma Canada.